References
- Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clinic. 2018;68(6):394–424.
- Consensus on chronic gastritis in China (2017, Shanghai). Chin J Digest. 2017;37(11):721–721.
- Rugge M, Meggio A, Pennelli G, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut. 2007;56(5):631–636.
- China consensus on the protocol of early gastric cancer screening (draft, 2017, Shanghai). Chin J Digest. 2018; 38(2):87–87.
- China experts consensus on the protocol of early gastric cancer screening (2017, Shanghai). Chin J Health Manage. 2018;12(1):8–8.
- Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study. Gut. 2019;68(9):1576–1587.
- Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol. 1996;10(20):1161–1181.
- Cho S-J, Choi IJ, Kook M-C, et al. Staging of intestinal- and diffuse- type gastric cancers with the OLGA and OLGIM staging systems. Aliment Pharmacol Ther. 2013;38(10):1292–1302.
- Rugge M, de Boni M, Pennelli G, et al. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther. 2010;31(10):1104–1111.
- Wang X, Cai L, Lu B. Application of the combination of serum Helicobacter pylori antibody detection and pepsinogen examination in screening gastric cancer and gastric precancerous lesions. Chin J Digest. 2016;36(9):582–582.
- Wang X, Lu B, Meng L, et al. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China. Scand J Gastroenterol. 2017;52(8):822–827.